Tilray Brands (TLRY) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025
Tilray Brands shares surged 44% to $12.15 Friday after reports that President Trump may direct agencies to reclassify marijuana as a Schedule III drug. Volume reached 84.2 million shares, with prices swinging between $10.32 and $13.85. The move follows Tilray’s 1-for-10 reverse stock split effective Dec. 2. Timing of any federal action remains uncertain.